# 



## 

## 

|Contents||||
|---|---|---|---|
||||Page|
|Reference and administrative|information|||
|Trustees'<br>annual<br>report|||2-8|
|Independent<br>auditors'<br>report|||9 -11|
|Statement offinancial activities|||12|
|(incorporating<br>an income and expenditure||account)||
|Balance sheet|||13|
|Statement ofcash flows|||14|
|Notes tothe Iinancial statements|||15|





## 

## 

|Trustees:||Chair|Andrew Duguid|Andrew Duguid||
|---|---|---|---|---|---|
|||Trustee|William Allen|(resigned|25.01.22)|
|||Trustee|Lawrence Bergstrom||(resigned 29.03.22)|
|||Trustee|Rajarshi Bhattacharyya|||
|||Trustee|Linda Gregory|||
|||Trustee|David Marriott|||
|||Trustee|Vicky Morgan|||
|||Trustee|Yelena Walters|||
|||Trustee|lan Hantson|(appointed 04.10.22)||
|Company|Secretary:|Yasmin D'Souza||||
|Chief Executive:||Fiona Hamilton||||
|Company|number:|04037209||||
|Charity number:||1085391||||
|Registered|office:|12,Grange Road, London, SE13BE||||
|||www. lso.ac.uk||||
|Auditors:||Goldwins<br>Limited||||
|||75Maygrove|Road|||
|||West Hampstead||||
|||London NW6|2EG|||
|||www, goldwins. co.uk||||
|Bankers||HSBC|Lloyds|Bank PLC||
|||Retail Unit 8|25 Gresham Street|||
|||38Canada Place<br>London||||
|||Canary Wharf|EC2V|7HN||
|||London||||
|||E145AH||||





## 

## 

## 



## 

## 

## 

|Reporting<br>per|formance|||||
|---|---|---|---|---|---|
|Inputs|Activities|Outputs|Outcomes|Impact||
|SDesign of|O Delivery of|O Professional|4 Acquisition<br>of|4 Personal and||
|the MOst I|the MOst I|&vocational|knowledge<br>and skills,|professional||
|BOst|BOst|training.|participation<br>in|development.||
|pathways.|pathways.|I patients|research, and transition|4 Graduates|join|
||O Outpatient|seen atthe|to autonomous|GOsC and||
||teaching dinic.|teaching|osteopathic practice.|contribute to||
|||clinic.|O Improved<br>patient|healthcare<br>in|their|
||||health; education|locality.||
||||regarding<br>posture,|4 patient access to||
||||exercise, lifestyle etc.|osteopathic||
|||||healthcare.||



## 

|MOst|Distinction|Merit|Pass||
|---|---|---|---|---|
|||1 (50%)|1 (509Q||
|Bost|First|Upper second|Lower second|Third|
||1 (14%)|2 (29%)||I (14%)|





## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

|Principal|Ms Fiona Hamilton||
|---|---|---|
|Registrar|Mrs Yasmin D'Souza||
|Finance Manager|Mr Nigel Martin||
|Course Leader|Dr Maria Fitzgerald<br>(PhD)||
|Director ofClinical Studies|Dr Lucy MacKay-Tumber|(EdD)|





## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 



## 

## 

|Forthe<br>ended||31 Au u|st 2022||||||
|---|---|---|---|---|---|---|---|---|
||||||||2022|2021|
|||||||Unrestricted|||
|||||||Fund|Total Fund|Total Fund|
||||||Note||E|E|
|Income from:|||||||||
|Charitable<br>activities|||||||||
|Education, training<br>Investments||and professional||development||1,211,034<br>1,073|1,211,034<br>1,073|1,095,411<br>20|
|Other||||||469|469|14,391|
|Total income||||||1,212,576|1,212,576|1,109,822|
|Expenditure<br>on:|||||||||
|Charitable<br>activities|||||6||||
|Education, training||and professional||development||1,107,107|1,107,107|1,029,211|
|Other|||||||||
|Total expenditure||||||1,107,107|1,107,107|1,029,211|
|Net income / (expenditure)|||for the year|||105,469|105,469|80,611|
|Transfers<br>between|funds||||||||
|Net income / (expenditure)|||before other recognised||||||
|gains and losses||||||105,469|105,469|80,61I|
|Net movement<br>In funds||||||105,469|1Q5,469|80,611|
|Reconciliation offunds:|||||||||
|Total funds brought||forward||||973,534|973534|892,923|
|Total funds carried||forward||||1,079,003|1,079,0Q3|973,534|





## 

|The London School OfOs<br>Balance sheet|The London School OfOs<br>Balance sheet|teopathy|||||||
|---|---|---|---|---|---|---|---|---|
|As at31 Au ust 2022||||||Company|no.|04037209|
||||||2022|||2021|
||||Note||6|||f|
|Fixed assets:|||||||||
|Tangible assets|||12||1,305,677|||1,336,267|
||||||1,305,677|||1,336,267|
|Current assets:|||||||||
|Debtors|||13|21,424||28,843|||
|Cash at bank and in hand||||411,030||256,264|||
|||||432„454||285,107|||
|Liabilities:|||||||||
|Creditors: amounts|falling|due within one year|14|(215,775)||(135,152)|||
|Net current assets|||||218,879|||149,955|
|Total assets less current||liabilities|||1,522,356|||1,486,222|
|Creditors: amounts|falling|due after one year|16||(443,353)|||(512,688)|
|Total net assets|||||1,079,003|||973,534|
|The funds ofthe charity:|||19||||||
|Restricted<br>income|funds||||||||
|Unrestricted<br>income funds:|||||||||
|Fixed assets fund||||830,369||803,570|||
|Building development||fund||40,000||40,000|||
|General funds||||208,634||129,964|||
|Total unrestricted|funds||||1,079,003|||973,534|
|Total charity funds|||||1,079,003|||973,534|



## 



|The London School OfOsteopathy<br>Statement ofcash flees|||||||
|---|---|---|---|---|---|---|
|Forthe<br>rended 31 Au ust 2022|||||||
|||Note|2022<br>f||2021<br>f||
|Cash flows from operating<br>activities||20|||||
|Net cash prcwided<br>by / (used in) operating activities||||224r)00||162,923|
|Cash flows from investing<br>activities:<br>Purchase offixed assets|||{3,186)||(2,098)||
|Net cash provided<br>by / (used in)investing~os||||{3,186)||(2,098)|
|Cash floes from financingectivitfes:<br>Repayments<br>ofborrowing|||(66')48)||(72,770)||
|Cash inflows from new borrowing|||||||
|Net cash provided<br>by / (used in) financingwctivities||||(66r)48)||(72,770)|
|Change in cash and cash equivalents|in the year|||154,766||88,055|
|Cash and cash equivalents<br>at the beginning<br>ofthe<br>year||||256,264||168,209|
|Cash and cash equivalents<br>at the end|ofthe year|21||411,030||256,264|





## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

|Detailed comparatlv|a|s<br>for|the stateme|nt ofRnancsal acthriues||||
|---|---|---|---|---|---|---|---|
||||||||2021|
||||||Unrestricted|Restricted|Total|
||||||E|E|E|
|Income from:||||||||
|Charitable<br>activities||||||||
|-Education,<br>training||and professional||development|1,095,411||1,095,411|
|Investments|||||20||20|
|Other|||||14,391||14,391|
|Total income|||||1,109,822||1,109,822|
|Expenditure<br>on:||||||||
|Charitable<br>activities||||||||
|-Education,<br>training||and professional||development|1,029,211||1,029,211|
|Total expenditure|||||1,029,211||1,029,211|
|Net income Iexpenditure|||before gains I (losses) on Investments||S0,611||80,611|
|Net gains<br>/ (losses)||on investments||||||
|Net Intxtme / expenditure|||||80,611||80,611|
|Transfers<br>between|funds|||||||
|Net movement<br>In funds|||||80,611||80,611|
|Total funds brought||forward|||892,923||892,923|
|Total funds carried||forward|||973,534||973,534|





## 

## 

## 

|Income from charitab|le<br>activi|ties||||||
|---|---|---|---|---|---|---|---|
|||||||2022|2021|
|||||Unrestrictedf|Restrictedf|Totalf|Totalf|
|Education,<br>training and professional<br>Funding<br>from Office for Students<br>Studentfees<br>CPD, access courses and other fees<br>Room hire|||development|138,964<br>952,130<br>316<br>8,038||138tm4<br>952,130<br>316<br>8,038|88,580<br>921,785<br>373<br>1,845|
|Outpatients<br>dink Income||||111,586||111486|82,828|
|Total income from charitable||activities||1,211.034||1,211,034|1,095,412|
|Income from investments||||||||
|||||||2022|2021|
|||||Unrestnctedf|Restrictedf|Toadf|Totalf|
|investment<br>income||||1,073||1,073|20|
|||||1,073||1,073|20|
|Other income||||||||
|||||||2022|2021|
|||||Unrestricted<br>f|Restrictedf|Total<br>f|Total<br>f|
|Tower Hamlets-Covid<br>JRSGrant|support|grant||469||489|5.000<br>9,391|
|||||469||469|14,391|



## 



## 




## 

## 

## 

|This is stated after char|ing|i cred|iting:|||
|---|---|---|---|---|---|
|||||2022|2021|
|||||8|L|
|Depreciation||||33,776|33,528|
|Operating<br>lease rentals:<br>Property||||86,500|32,440|
|Auditors'<br>remuneration<br>Audit|(excluding||VATI:|4,000|4,000|



## 

## 

|Staff costs were as follo|ws:|||||
|---|---|---|---|---|---|
|||||2Q22|2021|
||||||L|
|Salaries and wages<br>Social security costs<br>Employer's<br>contribution|to defined|pension|schemes|$70325<br>29,6TS<br>11,467|538,306<br>29,376<br>8,699|
|Freelance staff costs||||26,044|18,232|
|Staff training||||298|200|
|||||638,3Q9|S94,813|



## 

|(head coun|t based|on n|umber ofstaff employed)<br>during<br>the ye|ar was as follows:||
|---|---|---|---|---|---|
|||||2022|2021|
|||||No.|No.|
|Education,|training|and|professional|27.0|30.0|
|Outpatients<br>Support|clinic|||5.0<br>13.0|4.0<br>13.0|
|||||45.0|47.0|



## 



## 

## 

|||Freehold|Leasehold|Medical|Office||
|---|---|---|---|---|---|---|
|||Property<br>E|Costs<br>E|Equipment<br>E|Equipment<br>f|Total<br>E|
|Cost|||||||
|At the start|ofthe year|1,455,182|151,526|25,961|152,103|1,784,772|
|Additions<br>in year|||||3,186|3,186|
|Disposals<br>in year|||||||
|At the end|ofthe year|1,455,182|151,526|25,961|155,289|1,787,958|
|Depreciation<br>At the start|ofthe year|149,284|127,454|25,961|145,806|448,505|
|Charge for|the year|15,$75|15,153||2,748|33,776|
|Eliminated|on disposal||||||
|At the end|ofthe year|165,159|142,607|25,961|14$,554|482,281|
|Net book value|||||||
|At the end|ofthe year|1,290,023|8,919||6,735|1305,677|
|At the start|ofthe year|1,305,$98|24,072||6,297|1,336,267|



## 

|Debtors|||
|---|---|---|
||2022|2021|
||E|f|
|Other debtors|8494|7,344|
|Prepayments|12,830|21,499|
||21,424|28,$43|





## 

## 

## 

## 

|Creditors:amounts<br>falling due within one year|||
|---|---|---|
||2022<br>8|2021f|
|Mortgage<br>repayable<br>in one year (see Note 16)<br>Bank loans<br>Trade creditors|61,027<br>9,798<br>4,302|58,879<br>9,559<br>13,102|
|Overpaid<br>by Anglia Ruskin University<br>Student fees due by Anglia Ruskin<br>University<br>Other creditors<br>Accruals<br>Deferred income|121,468<br>(85,547)<br>13tfii7<br>36,306<br>34,454|45,122<br>(50,318)<br>1,868<br>34,373<br>22,567|
||215,775|135,152|
|Deferred Income|||
|Deferred<br>income comprises<br>student fees received|in advance off34,454 (2021:f22,567).||
||2022<br>6|2021f|
|Balance<br>at the beginning<br>ofthe year<br>Amount<br>released to income<br>in the year<br>Amount<br>deferred<br>in the year|22467<br>(22,567)<br>34,454|41,1 51<br>(41,151)<br>22,567|
|Balance at the end ofthe year|34,454|22,567|
|Creditors: amounts<br>falling due afier one year|2022f|2021|
|Mortgage (see below)<br>Mortgage<br>related costs<br>Bank loans|463,076<br>(48,795)<br>29,072|524,103<br>(50,285)<br>38,870|
||443,353|512,68$|



## 


|rene|gotiation<br>in the future.|||
|---|---|---|---|
|||2022|2021|
|||6||
|The|outstanding<br>balance at the year end was repayable as follows:|||
||In more than five years|195,247|265,892|
||Between two and five years|267 829|258 211|
||Total due after one year|463,076|524,103|
||Less than one year|61 027|58$79|
||Total|534,103|582,982|





## 

## 

## 

## 

|Analysis ofnet as|sets|between fund|s||||||
|---|---|---|---|---|---|---|---|---|
||||||General||||
||||||unrestrictedf|Designated<br>f|Restricted<br>f|Total funds<br>f|
|Tangible fixed assets|||||475,307|830,369||1,305,677|
|Net current assets|||||I76,679|40,000||216,679|
|Long term liabilities|||||(443,353)|||(443353)|
|Net assets at the|end|ofthe year|||208,633|870,369||1,079,002|
|Movements<br>In funds|||||||||
||||||Incoming|Outgoing|||
||||At|the start|resources<br>&|resources<br>&||At the end|
||||ofthe year<br>f||gains<br>f|losses<br>f|Transfers<br>f|ofthe year<br>f|
|Unrestricted<br>funds:|||||||||
|Designated<br>funds:|||||||||
|Fixed assets fund||||803,570||(33,776)|60,576|830,369|
|Building development||fund||40,000||||40,000|
|Tmal designated|funds|||843470||(33,776)|60476|870369|
|General funds||||129964|1,212476|(1,073330)|(60476)|208,634|
|Total unrnsuicted|funds||973,534||1,212,576|(1,107,107)||1,079,003|
|Total funds|||973534||1,212576|(1,107,107)||1,079,003|



## 

## 



## 

|20|Reconcglatlon ofne|t Income<br>/ (expendlmre|)|to net c|ash flow from|operating actM|des||
|---|---|---|---|---|---|---|---|---|
||||||||2022|2021|
||||||||f|f|
||Net Income / (expenditure)<br>fior the reporting|||period|||105rki9|80,611|
||(as per the statement of flnanclalactMties)<br>Depreciation<br>charges<br>(In«rease)/decrease<br>in debtors||||||33,776<br>7,419|33,528<br>35,872|
||Increase/(decrease)|in creditors|||||78,236|12,912|
||Net cash provided<br>by / (used In) operating||actMtles||||2242399|162,923|
|21|Analysis ofcash and cash equivalents||||At 1|||At31|
||||||September||Other|August|
||||||2021|Cash flows|changes|2022|
|||||||E|E|6|
||Cash in hand||||256,264|154,766||411,030|
||Total cash and cash|equivalents|||256,264|I54,766||411,030|



## 

|expir|ing<br>in April 2023 are as follows:|||
|---|---|---|---|
|||Leasehold|Property|
|||2022|2021|
|||f|E|
|Less <br>One|than one year<br> to five years|22,813|36,500<br>22,813|
|||22,813|59,313|



## 



## 

## 

## 

## 

|(a)Analysis ofne|t ass|ets between fu|nds (2021)|||||
|---|---|---|---|---|---|---|---|
|||||General||||
|||||unrestricted<br>f|Designatedf|Restricted<br>f|Total funds<br>f|
|Tangible fixed assets<br>Net current assets||||532,697<br>I09,955|803,570<br>40,000||I~6,267<br>149,955|
|Long term liabilities||||(512,688)|||(512,6$$)|
|Net~etsm<br>the|end|ofthe year||129,964|843470||973434|
|(b) Movements<br>In|funds (2021)|||||||
|||||Incoming|Outgoing|||
||||At the start|resources<br>&|resources<br>&||At the end|
||||ofthe yearf|gainsf|losses<br>f|Transfers<br>f|ofthe year<br>f|
|Unrestricted<br>funds:||||||||
|Designated<br>funds:<br>Fixed assets fund|||763,802||(33,528)|73,296|803,570|
|Building development||fund|40,000||||40,000|
|Total designated|funds||803,802||(33,528)|73,296|843470|
|General funds|||89,121|1.109,822|(995.683)|(73.296)|129rNI4|
|Total unrestricted|funds||892g23|I,IQ9,822|(1,029,211)||973,534|
|Total funds|||892P23|1,1Q9,822|(1,029,211)||%73434|



